Mandate

Vinge has advised Beijer Byggmaterial in connection with entering into an agreement to acquire Karl Ekesiöö Bygghandel

June 25, 2019 M&A

Vinge has advised Beijer Byggmaterial AB (“Beijer Byggmaterial”) in connection with Beijer Byggmaterial entering into an agreement to acquire Karl Ekesiöö Bygghandel AB. Completion of the transaction is subject to customary conditions.

Karl Ekesiöö Bygghandel AB is operating two branches in attractive locations with substantial building activity in the metro-area of Stockholm, (where Beijer Byggmaterial earlier this year acquired the business of Bygg-Ole).

Beijer Byggmaterial is part of Stark Group, the largest retailer and distributor of building materials in the Nordic region with operations in Denmark, Greenland, Norway, Sweden and Finland.

Vinge’s team consisted of, among others, Jonas Bergström, Linda Sengul, Anna Thoms,  Desirée Sjöblom and Jesper Lindvall (M&A), Agnes Perbo (Corporate Commercial), Kristoffer Larsson (Real Property/Lease Agreements) and Sophia Holm (Employment).

Related

Vinge advises Atria Sverige in conjunction with an investment in Cookin Food

Atria Sverige has acquired a 25 per cent stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction has been performed through the acquisition of shares in Bite Delight AB, which owns Cookin Food Sweden AB. Atria holds an option to acquire the remaining shares in Bite Delight AB after 2028.
March 04, 2026

Vinge advises Revivo Group on the acquisition of Solidenergy

Revivo Group, a portfolio company of Helix Kapital, has acquired Solidenergy, a leading provider of surface treatment services in the Norwegian market. The company operates within the energy, offshore and infrastructure sectors and is headquartered in Ågotnes outside Bergen. Solidenergy employs approximately 600 people.
March 03, 2026

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue which is expected to provide Oncopeptides with proceeds of approximately SEK 200 million before deduction of transaction costs.
March 03, 2026